Studies revised and directed at in-vitro and in-vivo characterization of an attenuated monovalent materials
Ended Project Grant Awarded Last action
- Award ID
- W911QY1510014
- Recipient
-
Profectus Biosciences, Inc. UEI DDRUDKNS37N8
- Awarding agency
-
ACC Aberdeen Proving Ground
Army Contracting Command, Department of Defense
- Obligated
- $3,570,155
Award facts
- Assistance listing
- 12.360 Research on Chemical and Biological Defense
- Completion date
- Originally
- Funding agency
- Joint PEO Chemical and Biological Defense Acquisition Support Center, Department of Defense
- Place of performance
- Baltimore, MD 21224, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | -$178 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $500,000 | |
| Amendment | $500,000 | |
| Amendment | -$500,000 | |
| Amendment | $0 | |
| Amendment | $1,991,129 | |
| Original award | $1,079,204 |
Quick answers
Who received award W911QY1510014?
W911QY1510014 was awarded to Profectus Biosciences, Inc. by ACC Aberdeen Proving Ground (Army Contracting Command) on July 17, 2015.
How much is award W911QY1510014 worth?
$3,570,155 has been obligated on W911QY1510014.
Which agency awarded W911QY1510014?
ACC Aberdeen Proving Ground (Army Contracting Command) awarded W911QY1510014, with funding from Joint PEO Chemical and Biological Defense (Acquisition Support Center).
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award